JANX — Janux Therapeutics, Inc.
6 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about JANX (2026-11-06)
- Janux Therapeutics reported Q3 2026 financial results, beating EPS estimates by $0.13.
- Revenue reached $9.29 million, surpassing estimates by $2.87 million.
- The company issued a press release on November 5, 2026, detailing these financial outcomes.
| Bluesky | 2 | community |
| GDELT | 2 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |